Cargando…
Diabetes Mellitus Is Associated With Poor In‐Hospital and Long‐Term Outcomes in Young and Midlife Stroke Survivors
BACKGROUND: The incidence of ischemic stroke has increased among adults aged 18 to 64 years, yet little is known about relationships between specific risk factors and outcomes. This study investigates in‐hospital and long‐term outcomes in patients with stroke aged <65 years with preexisting diabe...
Autores principales: | MacIntosh, Bradley J., Cohen, Ellen, Colby‐Milley, Jessica, Fang, Jiming, Zhou, Limei, Ouk, Michael, Wu, Che‐Yuan, Shah, Baiju R., Lanctôt, Krista, Herrmann, Nathan, Linkewich, Elizabeth, Law, Marcus, Black, Sandra E., Swartz, Richard H., Kapral, Moira K., Edwards, Jodi D., Swardfager, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483482/ https://www.ncbi.nlm.nih.gov/pubmed/34219470 http://dx.doi.org/10.1161/JAHA.120.019991 |
Ejemplares similares
-
Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
por: Wu, Che‐Yuan, et al.
Publicado: (2020) -
Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
por: Wu, Che‐Yuan, et al.
Publicado: (2022) -
Young Stroke Survivors With No Early Recurrence at High Long‐Term Risk of Adverse Outcomes
por: Edwards, Jodi D., et al.
Publicado: (2018) -
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021) -
The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
por: Ouk, Michael, et al.
Publicado: (2021)